ARTICLE | Clinical News
Sunshine Biopharma preclinical data
July 9, 2012 7:00 AM UTC
In vitro, Adva-27a killed significantly more multidrug-resistant SCLC tumor cells than generic etoposide. Adva-27a is a small molecule topoisomerase II (TOP2) inhibitor. ...